While there are myriad results for targeting alpha cells in T2D, it is important to also look further into T1D; for example, somatostatin’s role in inhibiting glucagon secretion in T2D warrants further study on its potential role in T1D. This evidence concerns the gene SST and type 1 diabetes mellitus.